Microsoft powerpoint - oral and injectable medication options for diabetes treatment(daphne).ppt
Identify the various classifications of oral
and injectable medication currently used in the treatment of diabetes mellitus
pharmacokinetics, dosing, adverse effects and drug interactions of each class of diabetes medications
Metabolic disorder characterized by hyperglycemia
¾Impaired pancreatic insulin secretion¾Increased hepatic glucose production¾Decreased peripheral glucose uptake
Glucagon
Islet-cell
(alpha cell)
dysfunction
Pancreas
resistance
Glucose uptake
Hyperglycemia
Adapted with permission from Kahn CR, Saltiel AR. Joslin’s Diabetes Mellitus. 14th ed.
Lippincott Williams & Wilkins; 2005:145–168.
1. Del Prato S, Marchetti P. Horm Metab Res. 2004;36:775–781. 2. Porte D Jr, Kahn SE. Clin Invest Med. 1995;18:247–254.
Sulfonylureas
Mechanism of Action (MOA): Stimulate insulin
secretion from pancreatic beta cells, reduces glucose output from liver, improves insulin sensitivity in periphery
Second Generation Sulfonylureas
¾ Glyburide Micronized (Glynase PresTab)
¾ Allergic skin reactions¾ Disulfiram-type
Drug Interactions
Drug Interactions
Precautions
Caution in elderly
Severe allergy to sulfonamides
Administration
Once daily-Twice daily dosing
Meglitinides
Biguanide-Drug of choice for Type 2
diabetes
Decreases intestinal absorption of glucose
Increases peripheral glucose uptake and
Products:
Adverse effects:
Kinetics:
Dosage: Once daily-
Drug Interactions: (Increased effects)
¾ Cationic drugs (e.g. Digoxin, Amiloride,
Contraindications:
¾ Renal disease (Cr >1.5 mg/dl Men, >1.4
Thiazolidinediones
Products:Rosiglitazone (Avandia)Pioglitazone (Actos)
Precautions:
CARDIAC: Black box warning
for increase in myocardial
ischemic events
Hepatotoxicity:
Kinetics:
Side Effects:
Drug Interactions
Lab disturbance:
Propranolol and Ranitidine concentrations
Contraindications
¾ Inflammatory Bowel Disease
Monitoring: LFTs every 3 months (Acarbose)
Dosing: Three times daily with first bite of
Available in combination with metformin (Janumet)
Very Rapid Acting
(Analogs)
70% NPH/ 30% Regular (
Humulin 70/30,
75% Lispro protamine/ 25% Lispro (
Humalog
70% Aspart protamine/ 30% Aspart (
Novolog
50% NPH/ 50% Regular (
Humulin 50/50 insulin)
50% Lispro protamine/50% Lispro (
Humalog
Available as prefilled pen for 5 mcg or 10 mcg dose
Indicated for
type 1
diabetes
and type 2
diabetes on insulin
Insulin dose is reduced
by 50% to avoid
hypoglycemia when
initiating pramlintide
Source: http://www.chtc.org/dl/handouts/20080108/Handout%202.pdf
The Catamaran Preferred Drug List is a guide identifying preferred brand-name medicines within select therapeutic categories. The Preferred Drug List may not include all drugs covered by your prescription drug benefit. Generic medicines are available within many of the therapeutic categories listed, in addition to categories not listed, and should be considered as the first line of p
Halleneinweihung 14. - 17.11. und 21. - 23.11.2008 Startliste Prüfung Nr.: 6C Start-Nr. WILOTTIE Tanja Stutz, Heimenhausen JOPPE VAN HALEN Florence Zumbühl, Urswil TROJA VII Hans Meier, Hagendorn Yasmin Wüest, Eschenbach MY DIAMOND STING Mikkel Thomsen, Birrwil CARBINO Z Sandra Schori, Kriegstetten QUANTAS KDR Z Dominik Wiesner, Zunz